Marcus A. Banks July 18, 2024 Some degree of pain is inevitable in older individuals, and as people pass 80 years of age, the harms of medications used to control chronic pain increase. Pain-reducing medication use in this age group may cause inflammation, gastric bleeding, kidney damage, or constipation. These risks may lead some clinicians...
Tag: <span>Buprenorphine</span>
Post
Rapid high-dose buprenorphine treatment strategy found to reduce opioid withdrawal in individuals using fentanyl
by Wiley Credit: Pixabay/CC0 Public Domain Buprenorphine is a medication approved for pain and opioid dependence. New findings published in The American Journal on Addictions indicate that a transmucosal dose (which dissolves in the mouth) of buprenorphine followed by an injection of extended-release buprenorphine (BUP‐XR) may be an effective treatment for individuals with opioid use disorder...
Post
Buprenorphine Cost a Potential Barrier for Opioid-Addicted Youth, Adults
by Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today August 7, 2023 article For young people with opioid use disorder (OUD), buprenorphine costs have declined overall but with drastic variation by payer type, researchers found. Examining buprenorphine prescriptions dispensed for U.S. youth ages 12 to 19, mean daily out-of-pocket costs declined 57.6% from 2015 through 2020 (from $4.03...
Post
Orally Dissolving Buprenorphine Tied to Severe Tooth Decay, FDA Warns
January 13, 2022 Orally dissolving medications containing buprenorphine are linked to severe dental problems, including total tooth loss, the US Food and Drug Administration (FDA) warns in a safety communication. The oral side effects of these medications, which are used to treat opioid use disorder (OUD) and pain, include cavities/tooth decay, including rampant caries; dental abscesses/infection; tooth erosion; fillings...
Post
Orally Dissolving Buprenorphine Tied to Severe Tooth Decay, FDA Warns
January 13 Orally dissolving medications containing buprenorphine are linked to severe dental problems, including total tooth loss, the US Food and Drug Administration (FDA) warns in a safety communication. The oral side effects of these medications, which are used to treat opioid use disorder (OUD) and pain, include cavities/tooth decay, including rampant caries; dental abscesses/infection; tooth erosion; fillings falling...
Post
Orally Dissolving Buprenorphine Tied to Severe Tooth Decay, FDA Warns
January 13, 2022 Orally dissolving medications containing buprenorphine are linked to severe dental problems, including total tooth loss, the US Food and Drug Administration (FDA) warns in a safety communication. The oral side effects of these medications, which are used to treat opioid use disorder (OUD) and pain, include cavities/tooth decay, including rampant caries; dental abscesses/infection; tooth erosion; fillings...
Post
Buprenorphine-naloxone effectively treats narcotic bowel syndrome in a long-suffering patient
by American College of Physicians The combination of buprenorphine and naloxone should be investigated as a potential treatment for narcotic bowel syndrome. The drugs seem to work together to address the underlying pathology of the syndrome. Findings from a brief research report are published in Annals of Internal Medicine. Narcotic bowel syndrome is a chronic...
Post
Continuity of buprenorphine treatment linked to significantly lower prescription opioid use and over
May 4, 2020 — A study at Columbia University Mailman School of Public Health found that long-term buprenorphine treatment is associated with improvements in health care outcomes. Compared to individuals who discontinued buprenorphine, those with continuous treatment had significantly lower rates of prescription opioid use and opioid-related events, including medically treated overdoses in the follow-up...
Post
Be Their Biggest Fan: 3 Things All Docs Should Know About Buprenorphine
Matthew F. Watto, MD; Paul N. Williams, MD; Stuart K. Brigham, MD Matthew F. Watto, MD: Hey guys, welcome back. We are the Curbsiders. Last month, we recorded a great interview, and we wanted to tell you some pearls we learned from it. But first, Paul, could you tell people what we do on the...